NCT00398008|WithdrawnPhase 2
Study Stopped
Study was never able to start in IRAN
Loading search results
Sponsor study identifier
Secondary identifiers
interventional
0
2 countries
2
Study Start
October 2004
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2006
Actual (reported)Study Completion
December 2008
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
A randomized, double blind clinical trial comparing buprenorphine and naltrexone maintenance treatment when combined with drug abuse and HIV risk reduction counseling (DC-HIV) for heroin and opium addicts in Iran.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2008
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 2004
Date type not reportedThis date has not been verified as actual or estimated.
November 9, 2006
Actual (reported)November 10, 2006
Actual (reported)December 2006
Actual (reported)December 2008
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Time to resumption of heroin use
26 weeks
Time to relapse
26 weeks
Maximum consecutive weeks of opiate abstinence
26 weeks
Reduction of HIV risks
26 weeks
Addiction-related functional status
26 weeks
Adverse events
26 weeks
DC-HIV plus buprenorphine maintenance.
DC-HIV plus naltrexone maintenance
Opioid agonist medication to treat opiate dependence
Opioid antagonist medication to treat opiate dependence
Yale University School of Medicine
New Haven, Connecticut, 06519, United States
Institute for Cognitive Studies
Tehran, Iran
Richard S. Schottenfeld, M.D.
Yale University
Azarakhsh Mokri, M.D.
Rouzbeh Hospital, Tehran, Iran
0 participants (actual enrollment reported by the registry).
First Submitted
November 9, 2006
First Posted
November 10, 2006
Study Start
October 2004
Date type not reportedThis date has not been verified as actual or estimated.
Comparison of HIV Clinic-based Treatment With Buprenorphine Versus Referred Care in Heroin-dependent Participants
DC-HIV: Drug Counseling that provides education about HIV, drug abuse and dependence; encourages medication adherence; uses motivational enhancement techniques; encourages life style changes; and teaches cognitive and behavioral coping skills to prevent relapse
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
December 2006
Actual (reported)Study Completion
December 2008
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
March 30, 2020
Record last verified: 2013-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: